ePrivacy and GPDR Cookie Consent by TermsFeed Generator

Detail of the clinical trial

Title of the trial A Randomized Multicenter Study Comparing Pixantrone + Rituximab with Gemcitabine + Rituximab in Patients with Aggressive B-cell Non-Hodgkin Lymphoma Who Have Relapsed after Therapy with CHOP-R or an Equivalent Regimen and are Ineligible for Stem Cell Transplant
EudraCT number 2012-001790-86
Protocol number PIX306
Sponsor CTI BioPharma, Corp.,3101 Western Avenue, Suite 600,Seattle WA 98121, United States of America
Indications Hemato-oncology
Diagnosis Aggresive B-cell Non-Hodgkin lymphoma
Population in clinical trial Adults (18-65 years)
Elderly ( > 65 years)
Male
Female
Patients
Year of receiving the request to Institute (SÚKL) 2014
Date of approval by Institute (SÚKL) 22.12.2014
Date of approval by EC 22.1.2015
Date of initiation CT in ČR 2.4.2015
Date of ending CT in ČR 12.10.218
Notice
Sites Všeobecná fakultní nemocnice v Praze,I. interní klinika - klinika hematologie,U Nemocnice 2,Praha 2,128 08
Fakultní nemocnice Hradec Králové,IV. interní hematologická klinika,Sokolská 581,Hradec Králové,500 05
Fakultní nemocnice Královské Vinohrady,Interní hematologická klinika,Šrobárova 1150/50,Praha 10,100 34
Fakultní nemocnice Ostrava,Klinika hematoonkologie,17. listopadu 1790,Ostrava,708 52
Fakultní nemocnice Brno,Interní hematologická a onkologická klinika,Jihlavská 20,Brno,625 00

‹‹ Back to list